Rami Komrokji

Dr. Komrokji is on the myelodysplastic syndromes (MDS) panel of the National Comprehensive Cancer Network (NCCN). He was a member of the editorial board for the Journal of Clinical Oncology (JCO) and is a peer reviewer for several medical journals including Blood, JCO, and Leukemia. He has authored or co-authored more than 175 peer-reviewed manuscripts, 20 book chapters, and more than 300 abstracts in hematologic malignancies. Dr. Komrokji’s research interests are in phase I and II clinical trials, and in outcomes research in hematologic malignancies with a focus on myeloid neoplasms. His clinical interests include MDS, acute leukemias, and myeloproliferative neoplasms.

Dr. Rami Komrokji received his medical degree from Jordan University School of Medicine. He completed an internship and residency at Case Western University, St. Vincent Program, and a fellowship at Strong Memorial Hospital, University of Rochester, in hematology/oncology and hematopoietic stem cell transplantation. Dr. Komrokji is Professor in Medicine & Oncologic Sciences at the College of Medicine at the University of South Florida in Tampa. In addition, he is a senior member of the Malignant Hematology and Experimental Therapeutics Program at the Moffitt Cancer Center. Dr. Komrokji is Vice Chair of the Malignant Hematology Department and the head of the Leukemia and MDS Section at the Moffitt Cancer Center, Tampa, Florida.